BIOT independently researches and develops the core patented technology, and uses it to produce collagen with a complete triple-helix structure, low immunogenicity, good biocompatibility, and biological activity, which is used as the basic raw material for medical biomaterials. Moreover, this raw material is traceable, non-immunogenic, non-pyrogenic, and has been proven safe and effective through years of clinical trials.
|

Medical instruments
|

Regenerative medicine
|

tissue engineering
|

medical cosmetology
|

Efficacy skin care
|